Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tatjana Fleck is active.

Publication


Featured researches published by Tatjana Fleck.


International Wound Journal | 2006

The management of deep sternal wound infections using vacuum assisted closure (V.A.C.) therapy

Tatjana Fleck; Ronny Gustafsson; Keith Gordon Harding; Richard Ingemansson; Mitchell D. Lirtzman; Herbert L. Meites; Reinhard Moidl; Patricia Elaine Price; Andrew J. Ritchie; Jorge D. Salazar; Johan Sjögren; David H. Song; Bauer E. Sumpio; Boulos Toursarkissian; Ferdinand Waldenberger; Walter Wetzel-Roth

A group of international experts met in May 2006 to develop clinical guidelines on the practical application of vacuum assisted closure™ (V.A.C.®) † therapy in deep sternal wound infections. Group discussion and an anonymous interactive voting system were used to develop content. The recommendations are based on current evidence or, where this was not available, the majority consensus of the international group. The principles of treatment for deep sternal wound infections include early recognition and treatment of infection. V.A.C. therapy should be instigated early, following thorough wound irrigation and surgical debridement. V.A.C. therapy in deep sternal wound infections requires specialist surgical supervision and should only be undertaken by clinicians with adequate experience and training in the use of the technique.


Interactive Cardiovascular and Thoracic Surgery | 2009

Extended videoscopic robotic thymectomy with the da Vinci telemanipulator for the treatment of myasthenia gravis: the Vienna experience.

Tatjana Fleck; Michael Fleck; Michael R. Müller; Helmut Hager; Walter Klepetko; Ernst Wolner; Wilfried Wisser

Surgical treatment of myasthenia gravis should include the complete resection of the thymus with the whole fatty tissue adherent to the pericardium for immunologic as well as oncologic reasons. The aim of the current study was to investigate the efficacy and safety of robotic approach. A total of 18 patients with myasthenia gravis (mean age 44 years) have been operated robotically via a left-sided approach. Preoperative MGFA (Myasthenia Gravis Foundation of America) classification was: Class I n=4, Class IIa n=4, Class IIb n=5, and Class IIIa n=3, IIIb n=2. Total endoscopic resection was feasible in 17/18 patients. One patient had to be converted due to bleeding. In the remaining patients, operative time was 175 min, intensive care unit (ICU) one day, hospital stay four days. In all patients it was possible to perform an extended thymic resection. MGFA post-intervention status after a mean of 18 months follow-up showed complete stable remission n=5, pharmacologic remission n=4, minimal manifestations n=5, unchanged n=1. Complete endoscopic thymus surgery with the da Vinci surgical system enables a complete and extended resection of all thymic tissue in the mediastinum. Due to the minimal trauma, patients can return to full activity within a short time.


International Wound Journal | 2009

V.A.C.® Therapy in the management of paediatric wounds: clinical review and experience

Mona M. Baharestani; Ibrahim Amjad; Kim Bookout; Tatjana Fleck; Allen Gabriel; David A. Kaufman; Shannon McCord; Donald Moores; Oluyinka O. Olutoye; Jorge D. Salazar; David H. Song; Steven Teich; Subhas C. Gupta

Usage of negative pressure wound therapy (NPWT) in the management of acute and chronic wounds has grown exponentially in the past decade. Hundreds of studies have been published regarding outcomes and methods of therapy used for adult wounds. This treatment is increasingly being used to manage difficult‐to‐treat paediatric wounds arising from congenital defects, trauma, infection, tumour, burns, pressure ulceration and postsurgical complications in children, although relatively few studies have been aimed at this population. Given the anatomical and physiological differences between adults and children, a multidisciplinary expert advisory panel was convened to determine appropriate use of NPWT with reticulated open cell foam (NPWT/ROCF) as delivered by Vacuum Assisted Closure® (V.A.C.® Therapy, KCI Licensing, Inc., San Antonio, TX) for the treatment of paediatric wounds.


Interactive Cardiovascular and Thoracic Surgery | 2008

Management of open chest and delayed sternal closure with the vacuum assisted closure system: preliminary experience

Tatjana Fleck; Bernhard Kickinger; Reinhard Moidl; Ferdinand Waldenberger; Ernst Wolner; Martin Grabenwoger; Wilfried Wisser

The management of open chest with the vacuum assisted closure (VAC) system was evaluated in terms of impact on cardiac hemodynamics, respiratory parameters, complications, incidence of wound infection, overall handling and outcome in 22 patients during 2005 and 2008 after cardiac surgery. The decision to leave the sternum open was made electively in all patients at the time of primary operation or reexploration. In four patients the VAC was implanted during the primary operation. In the remainder the VAC was implanted after a mean of five days after the primary operation. The overall mortality rate was 45% (10/22). None of the patients developed a sternal wound infection, nor were there any VAC related complications. Management of open chest with the VAC system can be considered as an alternative to sterile draping. The VAC has no negative impact on cardiac hemodynamics as well as respiratory mechanics. The feared complication of right ventricular rupture and massive bleeding can be effectively prevented. Through the stabilizing of the thoracic cage, the patient can be easily moved and mobilized for nursing reasons and pneumonia prevention. Furthermore, the VAC effectively prevents the contamination of the wound and the mediastinum with potential subsequent infection.


Interactive Cardiovascular and Thoracic Surgery | 2011

Triclosan-coated sutures for the reduction of sternal wound infections? A retrospective observational analysis

Stefan Stadler; Tatjana Fleck

OBJECTIVES Sternal wound infections are an infrequent but serious complication of cardiac surgery, leading to a prolonged hospital stay, increased costs and greater morbidity. To prevent bacterial colonisation of the suture material, which disables local mechanisms of wound decontamination, sutures coated with triclosan were developed. The current study set out to evaluate the effectiveness of such sutures against the development of sternal wound infections after cardiac surgery. METHODS Between October 2006 and October 2007, a total of 963 patients underwent cardiac surgery with a standard median sternotomy and cardiopulmonary bypass at the General Hospital of Vienna (AKH). A total of 198 patients had their wounds closed with normal sutures, and 765 with the new triclosan-coated sutures. Of these 765 patients, 678 received total closure (sternal fascia, subcutaneous tissue and skin) using the new sutures, whereas in 87 patients the new sutures were used only for the sternal fascia. The study was designed as not being double-blinded, and evaluation was carried out retrospectively. RESULTS The rate of sternal wound infection was 3.0% in the conventionally closed group, 2.3% in the group with only the sternal fascia closed using triclosan sutures, and 3.2% in the group with total triclosan suture closure (fascia, subcutaneous tissue and skin). CONCLUSIONS Triclosan-coated sutures therefore showed no advantage in avoiding or reducing sternal wound infections. As the cost of these new materials is higher, the rationale for using these sutures remains to be determined.


International Wound Journal | 2014

Negative pressure wound therapy for the treatment of sternal wound infections after cardiac surgery.

Tatjana Fleck; Michael Fleck

We retrospectively collected and analysed data from patients with sternal wound infections between 1995 and 2001, which were treated with different wound management strategies, and compared them with our patients from 2002 to 2011, who were treated with the sternal negative pressure wound therapy (NPWT). From 1995 to 2001, a total of 198 patients (group A) with a mean age of 65 ± 10 years developed sternal wound infection (67% deep) after cardiac surgery. Wound management consisted of surgical debridement and immediate sternal closure or open packing. From 2002 to 2011, a total of 326 patients (group B) (71% deep) were managed with NPWT at the time of surgical debridement. Total mortality was 10% in group A and 3·6% in group B. Recurrence rates were 34 and 8·5%, respectively, for the groups A and B. The meantime of NPWT was 11 days. In group B patients, 75% proceeded to sternal closure. With the introduction of NPWT, the treatment of sternal wound infections could be substantially improved. Particularly, the high recurrence rates could be minimised; furthermore, the goal to salvage the sternal bone is facilitated.


Interactive Cardiovascular and Thoracic Surgery | 2017

Direct sternal administration of Vancomycin and Gentamicin during closure prevents wound infection

Martin Andreas; Moritz Muckenhuber; Doris Hutschala; Alfred Kocher; Florian Thalhammer; Paul Vogt; Tatjana Fleck; Guenther Laufer

OBJECTIVES Deep sternal wound infection is still a major complication in patients undergoing cardiac surgery. We previously identified mammary artery harvesting as a risk factor for decreased antibiotic tissue penetration. In addition, other risk factors including diabetes may inhibit sufficient tissue penetration of perioperative antibiotic prophylaxis. A novel closure protocol applying 2 topical antibiotics and further recommendations for sternal wiring was introduced at our department to decrease the incidence of sternal wound infections. METHODS A 12-month period prior to (March 2013-February 2014) and after (July 2014-June 2015) the introduction of a novel sternal closure protocol was studied. All sternal wound infections resulting from an operation during this period were analysed. The closure protocol consisted of the intra-sternal application of vancomycin and the subcutaneous application of gentamicin. Furthermore, we increased the number of sternal wires for more uniform distribution of lateral forces. RESULTS Patients in both groups were comparable regarding demographic data and risk factors. Fifty-three out of 919 patients operated prior to the protocol change developed an infection (5.8%). The introduction of the novel sternal closure protocol reduced this number to 19 out of 932 patients (2.0%; P  < 0.001). A binary regression including common risk factors revealed a strong independent risk reduction by the novel protocol (OR 0.322, P  < 0.001). The number of sternal wires was not significant in this analysis. CONCLUSIONS The topical application of 2 antibiotic agents significantly reduced sternal wound infection. However, the results of this trial should be confirmed in a randomized trial.


Scientific Reports | 2018

CD4+CD28null T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery

Patrick Sulzgruber; Barbara Thaler; Lorenz Koller; Johanna Baumgartner; Arnold Pilz; Matthias Steininger; Sebastian Schnaubelt; Tatjana Fleck; Günther Laufer; Barbara Steinlechner; Max-Paul Winter; Georg Goliasch; Johann Wojta; Alexander Niessner

Post-operative atrial fibrillation (POAF) is postulated as a complex interaction of different pathogenic factors, suggesting inflammatory processes as a main trigger of this particular type of atrial fibrillation. Therefore, the study sought to assess the impact of cellular immunity on the development of POAF. Comparing patients developing POAF to individuals free of POAF the fraction of CD4+CD28null T Lymphocytes was significantly higher in individuals developing POAF (11.1% [POAF] vs. 1.9% [non-POAF]; p < 0.001). CD4+CD28null cells were independently associated with the development of POAF with an adjusted odds ratio per one standard deviation of 4.89 (95% CI: 2.68–8.97; p < 0.001). Compared to N-terminal Pro-Brain Natriuretic Peptide, the fraction of CD4+CD28null cells demonstrated an increased discriminatory power for the development of POAF (NRI: 87.9%, p < 0.001; IDI: 30.9%, p < 0.001). Interestingly, a pre-operative statin-therapy was associated with a lower fraction of CD4+CD28null cells (p < 0.001) and showed an inverse association with POAF (p < 0.001). CD4+CD28null cells proved to be predictive for the development of POAF after cardiac surgery. Our results potentially indicate an auto-immune impact of this preexisting, highly cytotoxic T cell subset in the pathogenesis of POAF, which might be modified via the anti-inflammatory potential of a pre-operative statin-therapy.


Archive | 2018

Organ Preservation During Open Thoracoabdominal Reconstruction

Stephane Mahr; Marlies Stelzmüller; Tatjana Fleck; K. Dimitrov; Doris Hutschala; Günther Laufer; Marek Ehrlich

Abstract Surgical repair of thoracoabdominal aortic aneurysms continues to be a challenging and demanding task. Ischemic injury to the visceral organs and spinal cord remains the most severe complication during this extensive surgery. Several organ perfusion techniques have dramatically decreased the incidence of this serious intra- and postoperative complication.


The Annals of Thoracic Surgery | 2007

Triclosan-Coated Sutures for the Reduction of Sternal Wound Infections: Economic Considerations

Tatjana Fleck; Reinhard Moidl; Alexander Blacky; Michael Fleck; Ernst Wolner; Martin Grabenwoger; Wilfried Wisser

Collaboration


Dive into the Tatjana Fleck's collaboration.

Top Co-Authors

Avatar

Ernst Wolner

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Wilfried Wisser

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Doris Hutschala

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Günther Laufer

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Fleck

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Alexander Blacky

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Alexander Niessner

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Barbara Steinlechner

Medical University of Vienna

View shared research outputs
Researchain Logo
Decentralizing Knowledge